ResMed ( NYSE: RMD and ASX: RMD.AX ) changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
We develop innovative products to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing.
The ResMed story
In 1981 Professor Colin Sullivan and colleagues at the University of Sydney developed the first continuous positive airway pressure (CPAP) device, the first successful, noninvasive treatment for obstructive sleep apnea (OSA). In 1989 ResMed was founded to commercialize a device for treating obstructive sleep apnea, a major subset of sleep-disordered breathing (SDB).Operations have grown dramatically in the past 25 years. Awareness about the dangers of untreated OSA has increased, and we have introduced new, highly innovative, product lines. ResMed now operates in 100 countries via direct offices and a network of distributors.
Since 1989, we have maintained our focus on SDB, while also expanding into the fields of respiratory medicine and cardiology. We help make quality care accessible for those with diseases such as chronic obstructive pulmonary disease and motor neuron disease.
Our mission is to provide global leadership in sleep medicine and non-invasive ventilation based on innovative technology advancing the diagnosis, treatment, and management of sleep-disordered breathing.
Aims and objectives
We are a global leader in the development, manufacturing and marketing of innovative medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing.
We sell high quality products for every step of the patient pathway — from diagnosis to treatment, in 100 countries through direct offices and a network of distributors.
We are advancing innovative technology in sleep and respiratory medicine. We incorporate this technology into innovative products that reach patients around the world. We will at all times act ethically in dealing with both customers and employees.